International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
South Asian Institute of Technology and Medicine bail South Asian Institute of Technology and Medicine The South Asian Institute of Technology and Medicine (SAITM) (originally known as the South Asian Institute of Technology and Management) is a privately owned educational institution providing higher education in Sri Lanka. It is recognised as a degree awarding institute under section 25A of the Universities Act No. 16 of 1978. It is the first private sector Green Campus to be established in the country. SAITM has become a highly controversial national issue with various segments questioning its standards and legality in terms of its operations as the only private medical college